Dimah A. Alaskar
YOU?
Author Swipe
View article: Pharmacological management of upper gastrointestinal Crohn’s disease: a systematic review
Pharmacological management of upper gastrointestinal Crohn’s disease: a systematic review Open
Background Upper gastrointestinal Crohn’s disease (UGICD) is an uncommon phenotype with limited management guidelines. We reviewed evidence on the safety and efficacy of pharmacological interventions for UGICD. Methods We searched MEDLINE,…
View article: Exploring intraprocedural performance in colonoscopy: Insights from a tertiary care center in Saudi Arabia
Exploring intraprocedural performance in colonoscopy: Insights from a tertiary care center in Saudi Arabia Open
Background: Colonoscopy is essential for diagnosing and managing colorectal conditions, and is recognized as the gold standard for early cancer detection and removal of precancerous lesions. The American Society for Gastrointestinal Endosc…
View article: Letter: Ozanimod and latent tuberculosis
Letter: Ozanimod and latent tuberculosis Open
LINKED CONTENT This article is linked to Fehily et al papers. To view these articles, visit https://doi.org/10.1111/apt.16952 and https://doi.org/10.1111/apt.17345
View article: Barriers to research productivity among gastroenterologists and hepatologists in Saudi Arabia
Barriers to research productivity among gastroenterologists and hepatologists in Saudi Arabia Open
Background: Clinical research is essential for the advancement of medical knowledge and evidence-based medical practice. In this study, we aimed to identify barriers that limit research productivity among gastroenterologists in Saudi Arabi…
View article: Risk of neutropenia in inflammatory bowel disease patients treated with TNF inhibitors: A single-center, retrospective cohort study
Risk of neutropenia in inflammatory bowel disease patients treated with TNF inhibitors: A single-center, retrospective cohort study Open
In this study, mild neutropenia was common among patients with IBD on TNFi. Future prospective studies are required to further clarify the significance of neutropenia in patients with IBD receiving TNFi.
View article: P666 Neutropenia in inflammatory bowel disease patients on TNF inhibitors: A single-centre, retrospective cohort study
P666 Neutropenia in inflammatory bowel disease patients on TNF inhibitors: A single-centre, retrospective cohort study Open
Background Tumor necrosis factor-α inhibitors (TNFi) have become the mainstay of treatment in moderate to severe cases of IBD. The haematological safety profile of these agents has been documented in multiple clinical trials and post-marke…